AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.380
-0.150 (-3.31%)
At close: Aug 28, 2025, 4:00 PM
4.380
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:11 PM EDT
AVITA Medical Stock Forecast
Stock Price Forecast
The 4 analysts that cover AVITA Medical stock have a consensus rating of "Strong Buy" and an average price target of $14.75, which forecasts a 236.76% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $21.
Price Target: $14.75 (+236.76%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVITA Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +82.65% | Aug 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +310.96% | Aug 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +333.79% | Jun 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +333.79% | Jun 6, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +402.28% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
82.39M
from 64.25M
Increased by 28.23%
Revenue Next Year
111.43M
from 82.39M
Increased by 35.24%
EPS This Year
-0.81
from -2.39
EPS Next Year
-0.31
from -0.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 107.8M | 142.0M | |||
| Avg | 82.4M | 111.4M | |||
| Low | 74.6M | 91.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.8% | 72.3% | |||
| Avg | 28.2% | 35.2% | |||
| Low | 16.1% | 10.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.22 | -0.11 | |||
| Avg | -0.81 | -0.31 | |||
| Low | -1.56 | -0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.